COMMUNIQUÉS West-GlobeNewswire

-
OSE Immunotherapeutics Receives Notice of Allowance for New Patent by U.S. Patent and Trademark Office that Further Strengthens Intellectual Property Portfolio Around Tedopi® in Immuno-Oncology Applications
25/01/2018 -
ProMIS Neurosciences to Present at Upcoming Investor Conferences
25/01/2018 -
Exagen Diagnostics announces collaboration with GSK to drive greater awareness about challenges facing lupus diagnosis and management
25/01/2018 -
Nextech Highlights NexCloud for Medical Spas at the American Med Spa Association Show
25/01/2018 -
Zealand Pharma hosts Capital Market Day: Accelerating the late stage pipeline
25/01/2018 -
ArmadaCare Appoints New Vice President of National Accounts
25/01/2018 -
Woebot Labs Launches Mobile App for iOS - Expanding Reach and Capability of Mental Health Chatbot
25/01/2018 -
Tempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer Patients
25/01/2018 -
UPDATE -- DLT Resolution to acquire 80% of fast growing Canadian start-up A.J.D. Data Services Ltd.
25/01/2018 -
Mariner Endosurgery Receives Health Canada Investigational Testing Approval for LaparoGuard Technology
25/01/2018 -
American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure
25/01/2018 -
UPDATE -- Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection
25/01/2018 -
Zosano Announces Results of Special Meeting of Stockholders and 1-for-20 Reverse Stock Split
25/01/2018 -
ArmadaCare Announces a New Suite of Supplemental Insurance Products
25/01/2018 -
Novan Announces First Patient Dosed in Phase 2 Molluscum Contagiosum Trial with SB206
25/01/2018 -
Albireo Prices $65.0 Million Public Offering of Common Stock
25/01/2018 -
Golden Leaf Subsidiary, Medical Marijuana Group, Receives First Shipment of Genetics to its Grow Facility in St. Thomas, Ontario
25/01/2018 -
Marrone Bio Innovations Announces Distribution Partnership in the Philippines
25/01/2018 -
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs
25/01/2018
Pages